Overview and Scope
Biologic imaging reagents refer to substances or compounds that are used in various imaging techniques to enhance the visibility and contrast of biological structures, molecules, or processes. These reagents are designed to interact specifically with specific biological targets, such as proteins, nucleic acids, or cellular structures, to make them more visible and distinguishable during imaging.
Sizing and Forecast
The biologic imaging reagents market size has grown rapidly in recent years. It will grow from $16.69 billion in 2023 to $18.41 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in prevalence of chronic diseases, growing research and development investments, shift towards personalized medicine, focus on early disease detection, increasing geriatric population, collaborations in biomedical research..
The biologic imaging reagents market size is expected to see strong growth in the next few years. It will grow to $25.72 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expanding applications in drug development, rising demand for molecular imaging, focus on non-invasive diagnostic methods, global increase in cancer cases, shift towards value-based healthcare.. Major trends in the forecast period include rise in demand for contrast-enhanced imaging agents, development of targeted molecular imaging agents, application of nanoparticles in imaging, emergence of fluorescent probes for in vivo imaging, integration of artificial intelligence in image analysis..
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report
Segmentation & Regional Insights
The biologic imaging reagents market covered in this report is segmented –
1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalites
3) By Application: In Vitro, In Vivo
4) By End User: Diagnostic Laboratories, Imaging Centres, Life Science Companies, Research And Academic Institutes, Other End Users
North America was the largest region in the biologic imaging reagents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp
Major Driver Impacting Market Growth
The increase in the prevalence of chronic diseases is expected to propel the growth of the biologic imaging reagents market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Chronic diseases require biologic imaging reagents to diagnose and detect diseases by visualizing organs and affected structures. For instance, in 2022, according to the American Cancer Society, a US-based voluntary organization, the number of new cancer cases and fatalities expected was estimated to be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Furthermore, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20–79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. The increase in the prevalence of chronic diseases is driving the growth of the biologic imaging reagents market.
Key Industry Players
Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc. , PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH </b
The biologic imaging reagents market report table of contents includes:
1. Executive Summary
2. Biologic Imaging Reagents Market Characteristics
3. Biologic Imaging Reagents Market Trends And Strategies
4. Biologic Imaging Reagents Market – Macro Economic Scenario
5. Global Biologic Imaging Reagents Market Size and Growth
.
.
.
32. Global Biologic Imaging Reagents Market Competitive Benchmarking
33. Global Biologic Imaging Reagents Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biologic Imaging Reagents Market
35. Biologic Imaging Reagents Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
